Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angelo Schenone

Showing results (111-120 of 199) with videos related to

Pageof 20
Sort By:
American Journal of Physical Medicine & Rehabilitation|June 18, 2011
Outcome measures and rehabilitation treatment in patients affected by Charcot-Marie-Tooth neuropathy: a pilot studyGiovanni Maggi, Margherita Monti Bragadin, Luca Padua, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|March 20, 2010
The spectrum of GNE mutations: allelic heterogeneity for a common phenotypeMarina Grandis, Rossella Gulli, Denise Cassandrini, et al.
Pain Medicine (Malden, Mass.)|January 7, 2020
High-Dose Intravenous Immunoglobulin Is Effective in Painful Diabetic Polyneuropathy Resistant to Conventional Treatments. Results of a Double-Blind, Randomized, Placebo-Controlled, Multicenter TrialStefano Jann, Raffaella Fazio, Dario Cocito, et al.
Neuromuscular Disorders : NMD|January 19, 2021
Maintenance treatment with subcutaneous immunoglobulins in the long-term management of anti-HMCGR myopathyAngela Zuppa, Chiara De Michelis, Giuseppe Meo, et al.
Journal of the Peripheral Nervous System : JPNS|June 15, 2007
Predictors of response to rituximab in patients with neuropathy and anti-myelin associated glycoprotein immunoglobulin MLuana Benedetti, Chiara Briani, Marina Grandis, et al.
Orphanet Journal of Rare Diseases|October 6, 2018
Autosomal-dominant transthyretin (TTR)-related amyloidosis is not a frequent CMT2 neuropathy "in disguise"Marina Grandis, Alessandro Geroldi, Rossella Gulli, et al.
Acta Myologica : Myopathies and Cardiomyopathies : Official Journal of the Mediterranean Society of Myology|February 26, 2024
Skeletal muscle involvement in biallelic <i>SORD</i> mutations: case report and review of the literatureSara Massucco, Chiara Gemelli, Emilia Bellone, et al.
Human Molecular Genetics|March 14, 2008
Different cellular and molecular mechanisms for early and late-onset myelin protein zero mutationsMarina Grandis, Tiziana Vigo, Mario Passalacqua, et al.
European Journal of Neurology|September 16, 2024
Repurposing chemotherapy-induced peripheral neuropathy gradingRoser Velasco, Andreas A Argyriou, David R Cornblath, et al.
Frontiers in Immunology|August 4, 2022
Case Report: Post-COVID-19 Vaccine Recurrence of Guillain-Barré Syndrome Following an Antecedent Parainfectious COVID-19-Related GBSMargherita Bellucci, Francesco Germano, Stefano Grisanti, et al.
Pageof 20

Showing results (111-120 of 199) with videos related to

Sort By:
Pageof 20
American Journal of Physical Medicine & Rehabilitation|June 18, 2011
Outcome measures and rehabilitation treatment in patients affected by Charcot-Marie-Tooth neuropathy: a pilot studyGiovanni Maggi, Margherita Monti Bragadin, Luca Padua, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|March 20, 2010
The spectrum of GNE mutations: allelic heterogeneity for a common phenotypeMarina Grandis, Rossella Gulli, Denise Cassandrini, et al.
Pain Medicine (Malden, Mass.)|January 7, 2020
High-Dose Intravenous Immunoglobulin Is Effective in Painful Diabetic Polyneuropathy Resistant to Conventional Treatments. Results of a Double-Blind, Randomized, Placebo-Controlled, Multicenter TrialStefano Jann, Raffaella Fazio, Dario Cocito, et al.
Neuromuscular Disorders : NMD|January 19, 2021
Maintenance treatment with subcutaneous immunoglobulins in the long-term management of anti-HMCGR myopathyAngela Zuppa, Chiara De Michelis, Giuseppe Meo, et al.
Journal of the Peripheral Nervous System : JPNS|June 15, 2007
Predictors of response to rituximab in patients with neuropathy and anti-myelin associated glycoprotein immunoglobulin MLuana Benedetti, Chiara Briani, Marina Grandis, et al.
Orphanet Journal of Rare Diseases|October 6, 2018
Autosomal-dominant transthyretin (TTR)-related amyloidosis is not a frequent CMT2 neuropathy "in disguise"Marina Grandis, Alessandro Geroldi, Rossella Gulli, et al.
Acta Myologica : Myopathies and Cardiomyopathies : Official Journal of the Mediterranean Society of Myology|February 26, 2024
Skeletal muscle involvement in biallelic <i>SORD</i> mutations: case report and review of the literatureSara Massucco, Chiara Gemelli, Emilia Bellone, et al.
Human Molecular Genetics|March 14, 2008
Different cellular and molecular mechanisms for early and late-onset myelin protein zero mutationsMarina Grandis, Tiziana Vigo, Mario Passalacqua, et al.
European Journal of Neurology|September 16, 2024
Repurposing chemotherapy-induced peripheral neuropathy gradingRoser Velasco, Andreas A Argyriou, David R Cornblath, et al.
Frontiers in Immunology|August 4, 2022
Case Report: Post-COVID-19 Vaccine Recurrence of Guillain-Barré Syndrome Following an Antecedent Parainfectious COVID-19-Related GBSMargherita Bellucci, Francesco Germano, Stefano Grisanti, et al.
Pageof 20